Yutkin Vladimir, Pode Dov, Pikarsky Eli, Mandelboim Ofer
Department of Urology, Hadassah Hebrew University Medical School, Jerusalem, Israel.
J Urol. 2007 Dec;178(6):2660-4. doi: 10.1016/j.juro.2007.07.118. Epub 2007 Oct 22.
Up to 90% of patients with high grade superficial bladder tumors experience tumor recurrence and up to 50% have progression despite bacillus Calmette-Guerin treatment. Natural killer cells have a major role in the mechanism of the response to bacillus Calmette-Guerin but the exact mechanisms are still elusive. The recently discovered natural cytotoxicity receptors are linked to the host response to viral infection and to cancer. We tested the hypothesis that tumor expression of natural cytotoxicity receptor ligands can serve as a predictive factor for the response to intravesical bacillus Calmette-Guerin in patients with nonmuscle invasive, high grade bladder cancer.
We developed a histochemical staining method for analysis of the ligands of the 3 known natural cytotoxicity receptors NKp30, NKp44 and NKp46 using genetically engineered fusion proteins and an automated image analysis system. We examined formalin fixed, paraffin embedded sections of specimens of transurethral bladder tumor resection from patients with primary, nonmuscle invasive, high grade bladder cancer who were subsequently treated with bacillus Calmette-Guerin. We compared natural cytotoxicity receptor ligand expression to the response to bacillus Calmette-Guerin immunotherapy.
Six of 17 patients (35%) had recurrence despite bacillus Calmette-Guerin treatment. Primary tumors from favorably responding patients expressed higher levels of ligands for all 3 fusion proteins (NKp30, NKp44 and NKp46 p = 0.0026, 0.027 and 0.044, respectively).
Bacillus Calmette-Guerin resistant, high grade, nonmuscle invasive bladder tumors express significantly lower levels of ligands of all 3 natural cytotoxicity receptors compared with bacillus Calmette-Guerin responsive tumors. This suggests that down-regulation of these ligands facilitates escape from the bacillus Calmette-Guerin effect. Furthermore, analysis of ligand expression, which can be performed on formalin fixed, paraffin embedded sections, may serve as a new predictive assay for the response to bacillus Calmette-Guerin.
高达90%的高级别浅表性膀胱肿瘤患者会出现肿瘤复发,尽管接受了卡介苗治疗,但仍有高达50%的患者病情进展。自然杀伤细胞在卡介苗反应机制中起主要作用,但其确切机制仍不清楚。最近发现的自然细胞毒性受体与宿主对病毒感染和癌症的反应有关。我们检验了这样一个假设,即自然细胞毒性受体配体的肿瘤表达可作为非肌肉浸润性高级别膀胱癌患者对膀胱内卡介苗反应的预测因素。
我们利用基因工程融合蛋白和自动图像分析系统开发了一种组织化学染色方法,用于分析3种已知自然细胞毒性受体NKp30、NKp44和NKp46的配体。我们检查了原发性非肌肉浸润性高级别膀胱癌患者经尿道膀胱肿瘤切除标本的福尔马林固定石蜡包埋切片,这些患者随后接受了卡介苗治疗。我们将自然细胞毒性受体配体表达与卡介苗免疫治疗反应进行了比较。
17例患者中有6例(35%)尽管接受了卡介苗治疗仍出现复发。反应良好患者的原发性肿瘤对所有3种融合蛋白(NKp30、NKp44和NKp46,p分别为0.0026、0.027和0.044)的配体表达水平更高。
与对卡介苗有反应的肿瘤相比,卡介苗耐药的高级别非肌肉浸润性膀胱肿瘤表达的所有3种自然细胞毒性受体配体水平显著降低。这表明这些配体的下调促进了对卡介苗效应的逃逸。此外,对配体表达的分析可在福尔马林固定石蜡包埋切片上进行,可能成为卡介苗反应的一种新的预测检测方法。